Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
6
×
detroit top stories
gene therapy
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
6
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
alzheimer's disease
cancer immunotherapy
cell therapy
fda
gilead sciences
merck
astrazeneca
bayer
clinical trials
drug prices
What
bio
roundup
pfizer’s
amid
bombast
cancer
caught
coronavirus
debate
develop
discussion
drug
efforts
meso’s
miss
pandemic
presidential
promise
response
tuesday’s
vaccine
viewers
acquisitions
ahead
albert
alzheimer’s
approval
asco
biggest
biogen’s
biopharmaceutical
bourla
branded
ceo
choices
commissioner
companies
company
congress
consumers
Language
unset
unknown
Current search:
startups
×
" gene therapy "
×
" detroit blog main "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel